Implanon receives FDA 'approvable' status
The US FDA has granted 'approvable' status to the contraceptive Implanon (etonogestral subdermal implant), manufactured by Akzo Nobel's human pharmaceutical business Organon.
The US FDA has granted 'approvable' status to the contraceptive Implanon (etonogestral subdermal implant), manufactured by Akzo Nobel's human pharmaceutical business Organon.
Implanon is a small, flexible rod, about the size of a matchstick, that contains etonogestral, a progestin. Once inserted under the skin, the rod continually releases a low dose of etonogestral into the bloodstream, which provides contraceptive protection.
'Organon recognises the market need for diversity in the contraceptive marketplace and Implanon will provide women in the US with a new method of contraception,' said Toon Wilderbeek, president of Organon International and member of Akzo Nobel's board of management.